NCT02631980View on ClinicalTrials.gov

HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
AnemiaPostoperative Blood Loss
Interventions
DRUG

IV iron

Intravenous iron 15 mg/kg (max 1000 mg) in 250 ml 0.9% saline

DRUG

IV placebo

Intravenous 0.9% saline (250 ml)

Trial Locations (1)

1211

University of Geneva, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT02631980 - HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ? | Biotech Hunter | Biotech Hunter